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Abstract
Context: The objective of this systematic review was to update a prior review and summarize the 
evidence on the impact of family planning reminder systems (e.g., daily text messages reminding 
oral contraception users to take a pill).
Evidence acquisition: Multiple databases, including PubMed, were searched during 2016–
2017 for articles published from March 1, 2011, to November 30, 2016, describing studies of 
reminder systems.
Evidence synthesis: The search strategy identified 24,953 articles, of which two studies met 
the inclusion criteria. In total with the initial review, four studies (including two RCTs) examined 
reminder systems among oral contraception users, with two of three that examined correct use 
finding a statistically significant positive impact, and one RCT finding a positive impact on 
knowledge and continuation. Of three studies (including two RCTs) that examined reminder 
systems among depot medroxyprogesterone acetate users, one of three that examined correct use 
found a statistically significant positive impact on timely injections at 3 months, and one study 
found no effect on continued use at 12 months.
Conclusions: Although this review found mixed support for the effectiveness of reminder 
systems on family planning behaviors, the highest quality evidence yielded null findings related to 
correct use of oral contraception and timely depot medroxyprogesterone acetate injections beyond 
3 months, and found positive findings related to oral contraception continuation and knowledge. 
Future studies would be strengthened by objectively measuring outcomes and examining 
additional contraceptive methods and outcomes at least 12 months post-intervention.
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Theme information: This article is part of a theme issue entitled Updating the Systematic 
Reviews Used to Develop the U.S. Recommendations for Providing Quality Family Planning 
Services, which is sponsored by the Office of Population Affairs, U.S. Department of Health and 
Human Services.
CONTEXT
Nearly half (45%) of U.S. pregnancies each year are unintended,1 meaning that at the time 
the pregnancy occurred, the pregnancy was unwanted or the woman became pregnant earlier 
than desired. Approximately 40% of unintended pregnancies occur among women who used 
their contraceptive method inconsistently or incorrectly.2 User-dependent contraceptive 
methods (e.g., oral contraception, depot medroxyprogesterone acetate [DMPA] injections, 
and condoms) require adherence by users to ensure method effectiveness, thus accounting 
for differences in typical and perfect use failure rates.3 Typical use failure rates refer to the 
effectiveness of different methods during actual use, including inconsistent or incorrect use, 
whereas perfect use failure rates refer to method effectiveness when users follow directions 
for use. Examination of population-based data has found disparities in contraceptive failure 
rates among subgroups of women, including those who are younger, those who belong to 
certain racial or ethnic minority groups, those who are cohabiting, and those with lower 
incomes.4
Non-adherence to combined hormonal contraception (e.g., not taking oral contraception pills 
as prescribed) increases the risk of ovulation5 and side effects (e.g., bleeding irregularities) 
that may lead to discontinuation6 and periods of non-coverage. DMPA users must also 
maintain regular dosing schedules because injections must be received within 14 weeks of a 
previous injection to ensure effective contraceptive action. Condoms require use during each 
act of intercourse during fertile periods to protect against unintended pregnancy. Given the 
importance of correct and continued contraceptive use to prevent unintended pregnancy and 
reduce the occurrence of side effects, it is important to identify interventions that can 
improve family planning behaviors and effectiveness among users. Reminder systems—
interventions intended to remind patients of some behavior to achieve a reproductive health 
goal, such as taking a pill, attending a clinic visit to receive a DMPA injection, or using a 
condom—are promising approaches.
During 2010–2011, the Centers for Disease Control and Prevention and the Office of 
Population Affairs conducted a systematic review summarizing the evidence on the impact 
of reminder systems in clinical settings to improve family planning outcomes.7 That review 
assessed all relevant evidence published from January 1, 1985, to February 28, 2011. Along 
with expert feedback and findings from two other complementary systematic reviews on the 
impact of contraceptive counseling and education in family planning programs,8,9 the 
information was used to develop national recommendations for providing quality family 
planning services.10
The objective of this systematic review is to summarize the body of evidence since the initial 
review. A cumulative assessment of the evidence is provided by combining findings from 
this and the initial review.
Zapata et al. Page 2
Am J Prev Med. Author manuscript; available in PMC 2019 July 18.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
EVIDENCE ACQUISITION
This systematic review is reported according to the PRISMA checklist.11 The methods for 
conducting this updated systematic review were similar to the approach used in the prior 
reviews and have been described elsewhere.12 Briefly, five key questions (KQs) were 
developed (Table 1) and an analytic framework (Appendix Figure 1, available online) 
applied to show the logical relationships between the population of interest (women of 
reproductive age receiving family planning services in a clinical setting); the reminder 
system intervention; and the outcomes of interest (long-term, medium-term, and short-term 
outcomes and client experiences). Search strategies were then developed that included the 
identification of key terms (Appendix Table 1, available online), which were used to search 
multiple electronic databases, including PubMed, to identify potential articles published 
from March 1, 2011, to November 30, 2016.
Selection of Studies
Retrieval and inclusion criteria were developed a priori and applied to the search results. 
Eligible studies met the following criteria: conducted in the U.S., Canada, Australia, New 
Zealand, or European countries categorized as “very high” on the Human Development 
Index13; published in English from March 1, 2011, to November 30, 2016; described a study 
that addresses at least one KQ; and were full-length articles (abstracts and letters to the 
editor were excluded). RCTs, nonrandomized trials, cohort, and case-control studies were 
included. Articles also had to evaluate a reminder system intervention in a clinic-based 
setting where family planning services were provided. Studies that focused solely on 
prevention of HIV or sexually transmitted infections, without a family planning component, 
or focused solely on males, were not considered.
Some inclusion criteria were specific to KQs. KQs 1–3 sought to examine the relationships 
between utilization of reminder systems and improved long-, medium-, and short-term 
outcomes and client experiences; thus, a comparison group was required for the study to be 
included. Among included studies, those that also examined barriers and facilitators or 
unintended negative consequences met the inclusion criteria for KQ 4 or 5.
Data Abstraction, Assessment of Study Quality, and Synthesis of Data
Detailed information was abstracted by a team of four abstractors and reviewed by two 
authors for relevance to contraceptive counseling; differences were reconciled by consensus. 
The quality of each piece of evidence was assessed using the grading system developed by 
the U.S. Preventive Services Task Force, and risk of bias was rated as low, moderate, or 
high.14 As different types of reminder systems are appropriate for different contraceptive 
methods, findings are reported by contraceptive method. Only newly identified studies from 
the updated search are summarized in detail in the text, although the total body of evidence 
from both the initial and updated searches are fully described in the evidence tables. Table 2 
summarizes the evidence base among oral contraception users, and Table 3 summarizes the 
evidence base among DMPA users. Appendix Table 2 (available online) describes the details 
of each study. Summary measures of association were not computed across studies because 
of the diversity of the interventions, study designs, and populations.
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EVIDENCE SYNTHESIS
For the updated review, the search strategy identified 24,953 articles (Figure 1). After 
removal of duplicates (n=10,157) and applying the retrieval criteria, 205 full-text articles 
were reviewed. Of these, two studies (described in three articles) met the inclusion criteria.
18,19,22
 Findings from two articles among oral contraception users are described together as 
a single piece of evidence because they used the same reminder system intervention and 
included the same sample of participants18,19; only the most recently published article from 
this study will be referenced in text moving forward.
Both newly identified studies were RCTs, one rated as having moderate risk for bias18 and 
the other rated as having high risk for bias.22 Both studies examined medium-term outcomes 
(continuation of oral contraception and correct use of DMPA [i.e., timely injections])18,22; 
one study also examined knowledge.18 Neither of the newly identified studies examined 
long-term outcomes, client experiences, unintended negative consequences associated with 
offering reminder system interventions, or barriers or facilitators facing clinics or clients 
related to offering or using reminder system interventions. Sample sizes ranged from 10022 
to 962,18 and participants from both studies were adolescents or women aged ≤ 25 years. 
Both studies recruited participants from urban health facilities, one from a family planning 
health center18 and the other from an academic general pediatric and adolescent medicine 
practice.22
Oral Contraception Users
The newly identified study that examined the impact of a reminder system intervention 
among oral contraception users found a statistically significant positive impact on 
continuation and knowledge at 6 months.18 This RCT included 962 sexually active women 
aged ≤ 25 years who owned a cell phone with text messaging functionality and requested 
oral contraception. Participants were randomized to receive or not receive 180 text messages 
over 6 months, sent daily at a designated time chosen by the woman to serve as a reminder 
to take their daily oral contraceptive pill. The messages included an introductory message, 
three reminders of how to change contact information or message time, 47 individual 
educational messages that were repeated up to four times, 12 two-way messages for quality 
control, and one concluding message. The educational text messages addressed six major 
dimensions of oral contraception knowledge, including mechanism of action, effectiveness, 
use, side effects, risks, and benefits. All women, regardless of study group, received 
protocol-based routine care, including contraceptive counseling by staff and an educational 
handout. At the 6-month follow-up, women in the intervention group had significantly 
(p=0.005) higher oral contraception continuation rates (n=480, 64%) compared with women 
in the control group (n=482, 54%, AOR=1.44, 95% CI=1.03, 2.00). Mean oral contraception 
knowledge scores were also significantly (p<0.001) higher at 6 months among women in the 
intervention group (25.5) compared with women in the control group (23.7), corresponding 
to a 7% and 3% increase in knowledge from baseline. In multivariable modeling, receipt of 
the text message intervention was the strongest predictor of mean 6-month oral 
contraception knowledge, with the intervention group compared with control group 
participants scoring an average of 1.6 points higher.
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Depot Medroxyprogesterone Acetate Users
The newly identified study that examined the impact of a reminder system intervention 
among DMPA users found a statistically significant positive impact on correct use (i.e., 
timely DMPA injections) for the first maintenance DMPA cycle after initiation (3 months), 
but not for the second or third maintenance cycles after initiation (6–9 months).22 This RCT 
included 100 adolescents aged 13–21 years using DMPA who had a cell phone with text 
messaging capability for personal use. Participants were randomized to receive or not 
receive an intervention that consisted of a welcome text message and daily text appointment 
reminders starting 72 hours before their scheduled clinic visit, with the option to cease the 
messages by responding with their plans to attend the visit. If the adolescent responded “no” 
that she could not attend her appointment, an e-mail was automatically sent to the nurse case 
manager who contacted the adolescent for rescheduling. The intervention group also 
received scheduled health messages regarding condom use for sexually transmitted infection 
prevention, healthy weight management, encouragement to call the nurse for problems, and 
a sexually transmitted infection screening reminder. All adolescents, regardless of study 
group, received standard of care, including an appointment card with the date of their next 
injection and automated clinic appointment reminders via home telephone. The proportion 
of adolescents who returned on time for their appointment was higher among those in the 
intervention group (n=50) compared with those in the control group (n=50) for the first 
(68% vs 56%) and second maintenance cycles after initiation (68% vs 62%), but not for the 
third maintenance cycle after initiation (73% vs 72%), although statistical testing was not 
reported. In linear regression analysis, adolescents in the intervention group returned sooner 
after scheduled appointments compared with those in the control group for the first 
maintenance cycle after initiation (p<0.05), but not for the second or third maintenance 
DMPA cycles after initiation. In this study, it is unclear if estimates were based on intent to 
treat, or if estimates were only among adolescents who returned for subsequent injections.
DISCUSSION
The cumulative review identified seven studies published from January 1, 1985, to 
November 30, 2016, that examined the impact of reminder system interventions in clinical 
settings among a broad age range of women (13–50 years) on family planning outcomes.
15–18,20–22
 In total, four studies examined the impact of daily reminder systems among oral 
contraception users,15–18 three examined correct use and found inconsistent findings,15,16,18 
and one examined continued use and knowledge of oral contraception and found a modest 
impact on both outcomes. Three studies in total examined the impact of reminder systems 
among DMPA users20–22; all three examined correct use and found inconsistent findings,
20–22
 and one examined continued use and did not find a statistically significant positive 
impact.21 Three studies included in the body of evidence examined either barriers for clients 
to achieving positive outcomes after utilizing reminder systems or barriers for clinics to 
offering reminder systems.16,17,21 No studies from the original or updated searches 
identified studies of reminder system interventions that examined long-term outcomes, client 
experiences, or unintended negative consequences associated with reminder system 
interventions.
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The three studies that examined the impact of reminder systems on correct use of oral 
contraception were from the initial review. Two found a statistically significant positive 
impact of the reminder system on perfect oral contraception adherence during three cycles. 
However, both assessed adherence via self-report and had high risk for bias. One was a 
retrospective historical nonrandomized controlled trial that examined daily e-mail messages,
16
 and the other was a prospective cohort study that examined use of a small reminder device 
that emitted a daily audible beep.15 The third study from the initial review used a stronger 
design (RCT) and a more objective measure of adherence (an electronic monitoring device 
that sent a wireless signal each time participants opened the device to remove a pill),17,23,24 
although it was also rated as having high risk for bias. In contrast to the first two studies, this 
third study found no significant impact of daily text messages on oral contraception 
adherence over 3 months.17
The one study that examined continued use of oral contraception and oral contraception 
knowledge was an RCT rated as having moderate risk for bias identified during the review 
update that used self-reported data to examine the effect of daily educational text messages 
for 6 months. This study found a significant modest effect on continuation and knowledge, 
which in other research has been associated with contraception adherence.25 Of note, the 
continuation rates at 6 months in both the intervention and control groups were lower than 
the 6-month oral contraception continuation rate reported from a large, prospective 
observational cohort study.26
Of the three studies that examined the impact of reminder systems on correct use of 
DMPA20–22 two were from the original review.20,21 One study from the original review was 
a retrospective cohort study conducted via chart review and rated as having high risk for 
bias20; this study found a statistically significant impact of receiving a wallet-sized reminder 
card with the date of the next DMPA injection and a reminder postcard shortly before the 
next injection appointment. The other two studies, one from the original review21 and one 
from the review update,22 had stronger designs (RCT), although both were rated as having 
high risk for bias. Both assessed timeliness of DMPA injections over longer follow-up 
periods (9–12 vs 3 months), with no significant effect of either a reminder letter 2 weeks 
prior to the upcoming injection appointment and repeated phone calls if an appointment was 
missed21 or daily text appointment reminders starting 72 hours before the upcoming 
injection appointment.22 The one study that examined the impact of a reminder system on 
continued use of DMPA, identified during the initial review, did not find a statistically 
significant positive effect of the intervention on DMPA continuation rates at the 12-month 
follow-up.21
The three studies that examined either barriers for clients to achieving positive outcomes 
after utilizing reminder systems or barriers for clinics to offering reminder systems16,17,21 
were all from the original review. Barriers for clients included costs associated with using 
the reminder system16,17 and not being able to individualize the time the reminder message 
was received.16 Barriers for clinics included reminder systems that were too intensive to be 
incorporated easily into most office settings (e.g., repeated phone calls, facilitation of 
appointment re-scheduling).21
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The effect of reminder systems in other areas of health behavior has been reported. Personal 
reminders, such as telephone calls or e-mails from healthcare providers, to patients have 
been shown to improve medication adherence for chronic disorders (e.g., hypertension),27,28 
as have electronic reminders automatically sent from healthcare providers to patients.29 One 
systematic review examined the use of mobile phone text message reminders in healthcare 
services (mostly related to HIV and diabetes) and found that about three quarters of 60 
studies included in the review found improved outcomes, including medication adherence 
and appointment attendance.30 Another systematic review examined the effectiveness of 
texting and mobile phone app interventions among adolescents to improve adherence to a 
wide range of preventive behaviors (e.g., clinic attendance, physical activity, weight 
management, sun protection, smoking cessation) and found that about half of the included 
studies demonstrated significant improvements with moderate standardized mean 
differences.31 Another systematic review limited to RCTs on the effect of mobile phone–
based interventions for improving contraception use specifically, which included three of the 
four RCTs included in this systematic review, concluded that there is limited evidence that 
interventions delivered by mobile phone can improve contraception use and that the cost 
effectiveness and long-term effects of these interventions remain unknown.32
The cost of implementing reminder systems likely varies by intervention type. The two 
studies in this review that reported cost as a barrier to clients reported a monthly charge of 
$5–$10 for the reminder system service, which consisted of either daily e-mails or text 
messages.16,17 Because the use of technology and availability of unlimited data plans has 
greatly changed since the time these studies were conducted, it is possible that cost to clients 
may no longer be an issue. No other studies included in this review presented data on 
intervention costs.
It may be that reminder systems to improve adherence with taking medications for health 
conditions that pose a risk to life have a greater potential to be effective. Women often have 
ambivalent feelings or conflicted desires toward pregnancy and having a baby,33–35 which 
may influence correct and continued contraceptive use irrespective of reminder systems. 
Whereas forgetfulness is a common reason reported for non-adherence to medications being 
used to treat medical disorders,29 contraceptive behaviors are also influenced by a complex 
host of factors including personal feelings and beliefs, concerns about side effects, changes 
in relationship status or partner influences, cultural values and norms, and healthcare system 
issues.2,36
The evidence summarizing the impact of reminder systems in clinical settings to improve 
family planning outcomes has several limitations, which should be considered when 
interpreting the evidence. Of the seven studies included in this review, none were determined 
to have a low risk for bias (i.e., high quality), and five were determined to have a high risk 
for bias (i.e., low quality).16,20–22 Studies were considered to be at risk for bias because of 
selection bias,15,16,21 self-report bias,15,16,18 recall bias,15,18 or short follow-up times for 
behavioral outcomes.16–18,20–22 Participation rates were low in one study18 and not reported 
in two studies.15,21 Some studies failed to report comparability between study groups16,20,22 
and one included study groups that appeared to differ related to important background and 
reproductive health characteristics,15 limiting the ability to definitely attribute outcomes to 
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the reminder system. Attrition bias was also an issue for some studies; one did not report the 
percentage of participants completing the study15 and two did not report the comparability 
between participants who completed and did not complete the study.16,20 One study was not 
powered to detect longitudinal efficacy of the intervention.22 Among the included RCTs,
17,18,21,22
 primary weaknesses included lack of18,22 or not reporting investigator blinding,21 
not reporting on allocation concealment,21,22 and not reporting on randomization 
procedures.22 Last, given that contraceptive behaviors are influenced by a multitude of 
personal and relationship factors, it would have been helpful if studies had considered 
findings in light of potential changes in relationship status or pregnancy desires.
Despite these limitations, the evidence base for the impact of reminder system interventions 
in clinical settings on family planning outcomes also has several strengths. Four of seven 
studies in this review were RCTs,17,18,21,22 three of which used computer-generated 
randomization for group assignment.17,18,21 Two studies were conducted in multiple centers.
15,16
 One study followed participants for 12 months.21 Other strengths included high 
participation rates in two studies,17,22 high completion rates in one study,17 small differences 
in follow-up rates between study groups in two studies,17,18 and study groups with similar 
baseline characteristics in three studies.17,18,21 One study used an objective measurement of 
oral contraceptive adherence (i.e., electronic monitoring devices),17 and three studies 
validated information on DMPA injections using clinic records.20–22
At least one additional article meeting the inclusion criteria for this systematic review has 
been published since the systematic search of the literature. This article37 describes longer-
term, post-trial data among a subset of adolescents from a study already included in this 
systematic review in which text reminders for an upcoming visit had no effect on timely 
DMPA injections.22 In the article,37 among 87 of the original 100 enrolled adolescents who 
completed three maintenance DMPA injection cycles, intervention participants had 3.65 
increased odds of continuing to use DMPA or a contraceptive implant at the 20-month 
follow-up compared with control group participants (95% CI=1.26, 10.08). These findings 
are difficult to interpret given that youth who have already completed three maintenance 
DMPA injection cycles may be more motivated to continue using the method compared with 
youth who discontinued the method before the third maintenance injection.
CONCLUSIONS
Although this updated review found mixed support for the effectiveness of reminder system 
interventions, the studies with the most rigorous designs yielded null findings related to 
correct use of oral contraception and timely DMPA injections beyond 3 months, and found 
positive findings related to oral contraception continuation and knowledge. In general, these 
deductions are consistent with those from the initial review; only two new studies were 
added to the evidence base for this updated review. There is limited evidence available on 
the impact of reminder systems that makes it difficult to draw conclusions about when and 
for whom they might be effective. Technology is constantly changing, however, including 
advanced use of electronic medical records and patient portals, creating new opportunities to 
employ reminder system interventions to improve health outcomes, including those related 
to family planning. Future studies that examine the potential utility and cost effectiveness of 
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reminder systems might be beneficial. These studies would be strengthened by objectively 
measuring outcomes and examining additional contraceptive methods and behavioral 
outcomes at least 12 months post-intervention.
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Figure 1. 
Flow chart of study selection.
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